Does ethnicity moderate dementia's biomarkers?
Donald R Royall1, Raymond F Palmer,
1Department of Psychiatry, The University of Texas Health Science Center, San Antonio, TX, USA; Department of Medicine, The University of Texas Health Science Center, San Antonio, TX, USA; Department of Family and Community Medicine, The University of Texas Health Science Center, San Antonio, TX, USA; South Texas Veterans' Health System, Audie L. Murphy Division GRECC, San Antonio, TX, USA.
Researchers identified a dementia-specific cognitive performance measure (δ) linked to 12 serum biomarkers in Alzheimer's disease patients. These findings were specific to non-Hispanic white participants.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Alzheimer's Disease Research
Background:
- Distinguishing dementia-related cognitive decline from other factors is crucial for accurate diagnosis and research.
- Existing cognitive measures may contain noise unrelated to the dementing process.
- Identifying specific biomarkers associated with dementia can improve understanding and treatment.
Purpose of the Study:
- To develop a dementia-specific phenotype (δ) from cognitive task performance using structural equation models.
- To investigate the association between this dementia-specific phenotype (δ) and serum biomarkers in an Alzheimer's disease cohort.
- To determine if these associations are specific to certain demographic groups.
Main Methods:
- Utilized structural equation models to isolate dementia-relevant variance (δ) in cognitive performance.
- Analyzed data from the Texas Alzheimer's Research and Care Consortium, a well-characterized Alzheimer's disease cohort.
- Associated the continuous variable δ with various serum biomarkers, controlling for covariates.
Main Results:
- A relatively error-free, dementia-specific continuous variable (δ) was established.
- δ was significantly associated with 12 serum biomarkers, independent of covariates.
- These significant associations were observed specifically in non-Hispanic white participants.
Conclusions:
- The developed dementia-specific phenotype (δ) offers a refined measure for Alzheimer's disease research.
- Serum biomarkers show significant associations with dementia-specific cognitive performance, particularly in non-Hispanic white individuals.
- Further research is warranted to explore the biological mechanisms and clinical implications of these biomarker associations.
More Related Videos
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
